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Supplementary Figure 1. Mouse iPS cell colonies 
generated in the absence of VPA before (left) and after 
(right) trypsinization and replating the cells. Top, 
brightfield; bottom, GFP fluorescence. 
Supplementary Figure 2. Immunocytochemical characterization of human iPS cells generated by Sleeping Beauty transposon-
mediated reprogramming. A typical iPS clump was examined by confocal microscopy after staining with antibodies against pluriopotency 
markers: Oct4 and Nanog (DAPI- blue, Oct4- green, Nanog- red) (A), SSEA4 (B) and podocalyxin (C). FACS analyses showed that iPS cells are 
positive for SSEA4 (D) and podocalyxin (E). For FACS images, median values and gated percentages are presented. IK in parantheses stands 
for the median isotype control.  
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Supplementary Figure 3. Immunocytochemical characterization of human iPS cells generated by Sleeping 
Beauty transposon-mediated reprogramming. In comparison with HFF cells, human iPS cells showed decreased 
expression of CD44 and CD73 markers that are characteristic to more differentiated cellular phenotypes. Median values 
and gated percentages are presented. IK in parantheses stands for the median isotype control. 
Supplementary Figure 4. Heatmap of expression profiles of 
pluripotency-associated genes in four different human iPS cell clones, 





Supplementary Figure 5. COBRA-FISH analysis of human iPS and parental HFF cells. Slides with metaphase 
chromosomes were hybridized using multicolor COBRA-FISH. 48-color FISH staining every chromosome arm in a 














Supplementary Figure 6. Silencing of transgenes in stable human iPS cells. (A) Transgene-specific PCR primers permit 
determination of relative expression levels between endogenous (endo) OCT4, SOX2, MYC and KLF4 genes and SB-expressed 
(Tg Sox2-2A-Klf4) transgenes via qRT-PCR. HFF cells transfected with the SB-based reprogramming vector (HFF-transfected) 
served as an early time-point sample. (B) The SB integration locus is transcriptionally active in pre-iPS colonies, and express 
mCherry. In stable human iPS cell lines, mCherry is silenced, but can be reactivated by 5-Aza-2'-Deoxycytidine (5-Aza).  
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Supplementary Figure 7. mRNA expression analysis of specific differentiation markers. Differentiation assays were carried out by 
generating EBs for 6 days (EB day 1-6). Six days later EBs were placed onto gelatin-coated plates. The attached cells differentiated 
spontaneously, the differentiation process being followed for up to 14 additional days, with mRNA harvests at days 3, 7, 11, 14 (day 6+3, day 
6+7, day 6+11, day 6+14). For gene expression analysis quantitative real-time PCR was carried out on cDNAs obtained after total RNA 
extraction and reverse transcription. HFFs were negative for Nanog (A), Oct4 (B) and Pax6 (C) and positive for CAPG (D). After 
reprogramming, iPS cells (clone 5, obtained with 5 factors, 5F C5) expressed Oct4 and Nanog, whose expression declined during 
differentiation. Differentiating cells acquired Pax6 expression during the late stages of differentiation, probably in parallel with the appearance 
of neuron-like cells. CAPG expression characteristic to skin cells showed a high expression level in the initial HFFs, and its expression 






Supplementary Figure 8. Generation of mouse iPS cells with pT2-OSKML and pT2-OSKM-mir302/367 vectors. 5X105 mouse OG2 
cells were electroporated with 500ng of either pT2-OSKML or pT2-OSKM-miR302/367 transposon- and 50ng of SB100X transposase 
vectors. After electroporation, cells were seeded to one geltrex-coated well of a 6-well plate and grown in mouse iPS medium in the 
absence of valproic acid. OG2 cells electroporated with the pT2-OSKML vector formed typical pre-iPS colonies described before and, at a 
later stage, typical mouse ES-like iPS colonies, which started to express GFP fluorescence together with the appearence of clump-like 
patches in the pre-iPS colonies. In contrast, OG2 cells electroporated with pT2-OSKM-miR302/367 retained a “flat” morphology all the 
way through the reprogramming process, generating distinctive iPS “nests” and pre-iPS colonies, which at a later stage formed GFP 
positive clones with a “flat” morphology reminescent of epiblast-derived stem cells (EpiSCs).  
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Supplementary Figure 9. Chromosomal mapping of Sleeping Beauty transposon insertion in the mouse genome. The SB 
transposon was integrated into a TA site on chromosome X, and there are no known protein coding and miRNA genes in a window of ±20 
kb around the transposon insertion site.  
Supplementary Methods 
 
Primers used in this study 







linker MboI linker 
(-) 
p-GATCGTCCCTTAAGCGGAG-amino  
linker GTAATACGACTCACTATAGGGC  
Tbal rev3 CATGACATCATTTTCTGGA ATT  
Tbal CTTGTGTCATGCACAAAGTAGATGTCC  
Nested PCR 
nested AGGGCTCCGCTTAAGGGAC  
forward GCA ACGGCAGCTACAGCATGATGCAG Sox2-Klf4 
junction reverse CAGGAGGTCGTTGAACTCCTCGGTCTC 
800 bp 
forward TGACTGTGCCTTTAAACAGCTTGGA SB-mCherry 
junction reverse GCGTGGTGACCGTGACCCAG 
980 bp 
Sox2-2A-Klf4 forward CCCGCTGCGCCCAGTAGAC 















































































































forward CGGAGACCACGTTTCAAA AGA 
TERT 





















reverse TGCCTTTTTCTTAGGGCAGAG  















































































Determination of transgene silencing in stable human iPS cells. First, transgene-specific 
primers against mouse Sox2 and Klf4 were designed to determine the expression of 
reprogramming transgenes in human stable iPS cells by qRT-PCR as well as HFFs transfected 
with SB-based reprogramming vectors. Data was normalized to GAPDH expression. Secondly, 
stable human iPS cells was treated with 5-Aza-2'-Deoxycytidine (5-Aza) for two days followed by 
checking mCherry expression under fluorescence microscope. 
 
